Cite
Arevalo JF, Sanchez JG, Lasave AF, et al. Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture. J Ophthalmol. 2011;2011:584238doi: 10.1155/2011/584238.
Arevalo, J. F., Sanchez, J. G., Lasave, A. F., Wu, L., Maia, M., Bonafonte, S., Brito, M., Alezzandrini, A. A., Restrepo, N., Berrocal, M. H., Saravia, M., Farah, M. E., Fromow-Guerra, J., & Morales-Canton, V. (2011). Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture. Journal of ophthalmology, 2011584238. https://doi.org/10.1155/2011/584238
Arevalo, J Fernando, et al. "Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture." Journal of ophthalmology vol. 2011 (2011): 584238. doi: https://doi.org/10.1155/2011/584238
Arevalo JF, Sanchez JG, Lasave AF, Wu L, Maia M, Bonafonte S, Brito M, Alezzandrini AA, Restrepo N, Berrocal MH, Saravia M, Farah ME, Fromow-Guerra J, Morales-Canton V. Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture. J Ophthalmol. 2011;2011:584238. doi: 10.1155/2011/584238. Epub 2011 Mar 30. PMID: 21584260; PMCID: PMC3090772.
Copy
Download .nbib